T 0452/16 (rasagiline hemitartrate / GALENICUM) of 29.03.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T045216.20190329
- Date of decision
- 29 March 2019
- Case number
- T 0452/16
- Petition for review of
- -
- Application number
- 13154290.4
- IPC class
- A61K 31/135A61P 25/16A61K 9/20
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Immediate release tablets of rasagiline hemitartrate
- Applicant name
- Galenicum Health S.L.
- Opponent name
- -
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)European Patent Convention R 103(1)(a)Rules of procedure of the Boards of Appeal Art 11
- Keywords
- Substantial procedural violation - violation of the right to be heard (yes)
Reimbursement of appeal fee - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution.
3. Reimbursement of the appeal fee is ordered.